Aspire Biopharma Inc. (ASBP)
NASDAQ: ASBP
· Real-Time Price · USD
0.55
0.00 (0.71%)
At close: Aug 25, 2025, 3:50 PM
Aspire Biopharma Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -17.24M | -16.54M | -1.14M | -579.72K | -402.63K | -395.98K | -232.11K | -155.81K | -90.27K |
Interest Income | 625.42K | 795.33K | 548.68K | 260.67K | 439.41K | 269.49K | 516.15K | 255.48K | n/a |
Pretax Income | -18.9M | -17.02M | -1.24M | -579.72K | -402.63K | -395.98K | -232.11K | -155.81K | -90.27K |
Net Income | -30.13M | -28.25M | -12.47M | -581.21K | -403.12K | -396.46K | -232.59K | -155.81K | -90.27K |
Selling & General & Admin | 18.52M | 18.16M | 3.09M | 608.31K | 423.46K | 416.81K | 196.34K | 130.53K | 79.77K |
Research & Development | 739.34K | 396.95K | 144.36K | 38.5K | 46.27K | 46.27K | 35.77K | 25.27K | 10.5K |
Other Expenses | -77.41K | -77.41K | -144.51K | -67.1K | -67.1K | -67.1K | n/a | n/a | n/a |
Operating Expenses | 19.18M | 18.48M | 3.09M | 579.72K | 402.63K | 395.98K | 232.11K | 155.81K | 90.27K |
Interest Expense | 1.72M | 1.4M | 1.29M | 408.96K | 400.46K | 192.28K | 8.97K | n/a | n/a |
Selling & Marketing Expenses | 183.48K | 137.17K | 5K | 137.99K | 121.31K | 127.31K | 39.64K | 11K | 11K |
Cost & Expenses | 19.18M | 18.48M | 3.09M | 579.72K | 402.63K | 395.98K | 232.11K | 155.81K | 90.27K |
Income Tax Expense | n/a | n/a | n/a | 1.49K | 481.00 | 481.00 | 481.00 | n/a | n/a |
Shares Outstanding (Basic) | 49.33M | 7.77M | 7.77M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M |
Shares Outstanding (Diluted) | 49.33M | 7.77M | 7.77M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M |
EPS (Basic) | -3.25 | -3.21 | -1.16 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 |
EPS (Diluted) | -3.25 | -3.21 | -1.16 | -0.01 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 |
EBITDA | -25.99M | -24.63M | -8.98M | -415.84K | -238.76K | -232.11K | -232.11K | -155.81K | -90.27K |
EBIT | -28.42M | -27.07M | -11.58M | -579.72K | -402.63K | -395.98K | -232.11K | -155.81K | -90.27K |
Depreciation & Amortization | 2.44M | 2.44M | 2.6M | 163.87K | 163.87K | 163.87K | n/a | n/a | n/a |